With that in mind, AARP The Magazine published a list this month of the best places to retire on $30,000 a year. Surveys show Boomers have not saved enough for retirement, and many rely solely on Social Security payments. Boomers are nearly half a million dollars short when it comes to how much they've saved for retirement compared with how much they think they need, according to a TD Ameritrade survey from last year. And nearly a third say they wouldn't be able to live comfortably in retirement without Social Security benefits. The average couple receives $2,048 a month in benefits, according to the Social Security Administration. That's about $24,500 a year.
Top 5 Financial Companies To Own For 2015: Global X China Energy ETF (CHIE)
Global X China Energy ETF (the Fund) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the S-BOX China Energy Index (the Underlying Index). The Underlying Index is a free float adjusted, liquidity tested and market capitalization-weighted index that is designed to measure performance of the investable universe of companies in the Energy sector of the Chinese economy, as defined by Structured Solutions AG. Global X Management Company, LLC serves as the investment adviser to the Fund. Advisors' Opinion:- [By pamatlarge]
Investors looking to short a particular sector can choose from several Global X long ETFs. The Global X China Consumer ETF (CHIQ) concentrates its investments in consumer cyclical goods and consumer defense goods. The Global X China Energy ETF (CHIE) primarily holds stocks in coal, oil and utility companies. The Global X China Financials ETF (CHIX) only invests in financial services companies and real estate companies. The Global X China Industrials ETF (CHII) holds stocks in industrial companies and basic materials companies. The Global X China Materials ETF (CHIM) invests in basic materials stocks. The Global X China Technology ETF (CHIB) holds technology stocks as the core of its investments. All of these ETFs are particularly sensitive to sector downturns and general economic contractions.
Top 10 Healthcare Technology Stocks To Watch For 2014: OXiGENE Inc.(OXGN)
OXiGENE, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics to treat cancer and eye diseases in the United States. It primarily focuses on the development of vascular disrupting agents (VDAs) that disable and destroy abnormal blood vessels, which provide solid tumors a means of growth and survival, as well as associate with visual impairment in various ophthalmological diseases and conditions. The company?s products include ZYBRESTAT, which is in fosbretabulin in anaplastic cancer of the thyroid (FACT) trial?Phase 2/3 study for the treatment of anaplastic thyroid cancer; in fosbretabulin in advanced lung oncology (FALCON) trial?Phase 2 randomized and controlled study to treat non-small cell lung cancer; in Phase 2 Simon two-stage design study for the treatment of platinum-resistant ovarian cancer; and in Phase 2 randomized controlled study to treat platinum-relapsed but platinum sensitive ovarian cancer. Its products also comprise OXi4503 that is in Phase 1 dose-escalation study for the treatment of acute myelogenous leukemia and myelodysplastic syndromes; Phase 1b dose-ranging study to treat solid tumors with hepatic tumor burden; and Phase 1 dose-escalation study for the treatment of refractory solid tumors. In addition, the company?s products consist of ZYBRESTAT, which is in Phase 2 randomized, double-masked, placebo-controlled, single-dose study for proof-of-mechanism study in polypoidal choroidal vasculopathy. OXiGENE has a strategic collaboration agreement with Symphony Capital Partners, L.P. to support the advancement of ZYBRESTAT for oncology and ophthalmology, and OXi4503. The company was founded in 1988 and is headquartered in South San Francisco, California.
Advisors' Opinion:- [By Bryan Murphy]
In the very short run, OXiGENE Inc. (NASDAQ:OXGN) is overbought and probably due for a setback, not unlike the all the other one-day surges and subsequent pullbacks we've seen from the stock since February of this year. Today's pop from OXGN, however, is quite different than all the rest... this time, it's got a legitimate shot at following through on the upside effort. Ergo, this little biopharma name is actually one of the market's best 'trades' right now.
- [By Bryan Murphy]
For the second time in as many days, I find myself supporting the purchase of a suddenly-bullish stock by saying "this time is different". Yesterday I was talking about OXiGENE Inc. (NASDAQ:OXGN), but today I'm using the term to describe the bullishness that's unfurling with Neurometrix Inc. (NASDAQ:NURO). And just for the record, yes, I know the perils of the "this time is different" argument. I tend to cringe when I hear it, as (too much) experience has taught me that things are rarely different - patterns within the market play themselves out over and over again. In the case of NURO as well as OXGN though, I can put my finger on something specific that we've not yet seen.
- [By Bryan Murphy]
There's no denying that OXiGENE Inc. (NASDAQ:OXGN) has, if nothing else, an interesting pipeline. And for many investors, the prospect of one or two budding winners in development is more than enough reason to jump into a biotech stock. In the case of OXGN, however, there's a far more direct - and no less speculative - reason to become a shareholder. That reason? The stock's going higher.... seriously.
- [By Wallace Witkowski]
Shares of Oxigene Inc. (OXGN) �more than doubled on very heavy volume after the microcap biotech said a mid-stage study of its drug Zybrestat, when used with Roche�� Avastin, showed increased survival in ovarian cancer patients. Oxigene shares rallied 129% to $5.55 , and were one of the most heavily traded issues after hours with more than 4.2 million shares exchanging hands.
Top 10 Healthcare Technology Stocks To Watch For 2014: Carbonite Inc (CARB)
Carbonite, Inc. (Carbonite), incorporated on February 10, 2005, focuses on the development and marketing of personal computer backup software that enables users to backup, access, and restore data files online. Carbonite is a provider of online backup solutions for consumers and small and medium sized businesses (SMBs). The Company provides secure online backup solutions with anytime, anywhere access to files stored on its servers, which it calls the Carbonite Personal Cloud. In November 2012, the Company acquired Zmanda, Inc.
The Company�� backup solutions works automatically uploading encrypted copies of its customers��files to the Carbonite servers. The Company's customers can browse and share their photos, videos, and documents anytime, anywhere using a Web browser or its free iPad, iPhone, BlackBerry, and Android apps. As of December 31, 2012, the Company had subscribers in more than 100 countries, with subscribers based in the United States representing 94% of its total revenue for 2012.
The Company competes with CrashPlan, Mozy, SOS Online Backup, Apple, Google, Microsoft, Amazon, DropBox, SugarSync, Box and others.
Advisors' Opinion:- [By Seth Jayson]
Carbonite (Nasdaq: CARB ) is expected to report Q2 earnings around July 12. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Carbonite's revenues will grow 27.5% and EPS will remain in the red.
Top 10 Healthcare Technology Stocks To Watch For 2014: Swissquote Group Holding Ltd (SQN)
Swissquote Group Holding Ltd (Swissquote) is a provider of online financial and trading services in Switzerland. It operates an online bank that accepts deposits from its customers mainly in Swiss Francs, United States Dollars and Euros in current account form, as well as offers electronic dealing in shares, funds, options, warrants and bonds worldwide. Swissquote also provides stock brokerage services to self-directed investors and asset managers; custodian services against fees and foreign exchange; margin loans to customers against pledging of assets; fiduciary placements on behalf and at the risks of clients against commission fees and services to corporations for the management of their stock option programs, among others. Its financial portal swissquote.ch is an online platform providing the information that users need to conduct independent research on various investment vehicles. It is active domestically and abroad, including Dubai and Malta. Advisors' Opinion:- [By Tom Stoukas]
Swissquote Group Holding SA (SQN) surged 13 percent after agreeing to buy MIG Bank for an undisclosed price. Clariant AG lost 1.6 percent after UBS AG removed the maker of specialty chemicals from the list of its most preferred shares.
Top 10 Healthcare Technology Stocks To Watch For 2014: iShares S&P GSCI Commodity-Indexed Trust (GSG)
iShares S&P GSCI Commodity-Indexed Trust (the Trust), formerly iShares GSCI Commodity-Indexed Trust, issues units of beneficial interest, called Shares, representing fractional undivided beneficial interests in its net assets. Substantially all of the assets of the Trust consist of interests in the iShares S&P GSCI Commodity-Indexed Investing Pool LLC (the Investing Pool). The investment objective of the Trust is to seek investment results, through its investment in the Investing Pool, which correspond generally to the performance of the S&P GSCI Total Return Index (the Index). The Investing Pool is a limited liability company. The Investing Pool holds long positions in CERFs, which are futures contracts listed on the Chicago Mercantile Exchange, which have a term of approximately five years after listing and whose settlement at expiration is based on the value of the S&P GSCI Excess Return Index, or S&P GSCI-ER, at that time.
The Index is intended to reflect the performance of a diversified group of commodities. The Index reflects the value of an investment in the S&P GSCI-ER together with a Treasury bill return. The S&P GSCI-ER reflects the returns that are potentially available through a rolling uncollateralized investment in the contracts comprising the S&P GSCI. Barclays Global Investors International, Inc. is the sponsor of the Trust and the manager of the Investing Pool. Barclays Global Investors, N.A. is the trustee of the Trust.
Advisors' Opinion:- [By Charles Sizemore]
But things have changed over the past decade; correlations between commodities have increased. As commodity mutual funds and ETFs such as the PIMCO Commodity Real Return Fund (PCRDX) and iShares S&P GSCI Commodity-Indexed Trust (GSG) have become popular, commodities that once traded largely independently of each other now get lumped together and bought and sold as a group. Also, the financialization of commodities has caused their correlation to stocks to rise as well.
- [By Adam J. Wiederman]
Getty Images Bitcoin made headlines last year when the value of all outstanding pieces of the electronic currency reached nearly $10 billion. It's not just speculators drawn to the new currency. Many businesses are also attempting to cash in on this growth: Several public companies, including Zynga (ZNGA) and Overstock.com (OSTK), accept Bitcoins as a form of payment. Venture capitalist Marc Andreessen's firm has invested nearly $50 million in Bitcoin-related ventures, and it is looking to invest even more. And the Winklevoss twins -- who notoriously accused Facebook's (FB) Mark Zuckerberg of stealing their idea -- have been "in dialogue" with the SEC about opening the first Bitcoin exchange-traded fund, according to Bloomberg. Yet a new survey from TheStreet.com (TST) reveals that 76 percent of consumers are not familiar with Bitcoin -- and 79 percent would never consider owning a currency like it. Does this signal opportunity for savvy investors? Or is this a fad you'd be wise to avoid? The Basics of Bitcoin Bitcoin is a completely unregulated form of currency developed by an anonymous Japanese programmer (according to some apocryphal claims) as a completely digital, peer-to-peer payment system that is independent of national currencies (which, Bitcoin users argue, are all subject to the riskiness of the underlying country). Bitcoins are rewarded throughout the day to a "Bitcoin miner" whose computer solves a series of algorithms quicker than other miners. The puzzles become more difficult over time, so the calculations take longer and the computations require more computing power. There will eventually be a total of 21 million Bitcoins (12.4 million are in circulation today) and we won't reach the point that they are effectively "mined out" until 2040. The value of a Bitcoin is supposed to be market-driven, meaning they're worth whatever the two parties in a transaction value them as. For example, in one of the original Bitcoin transactions, a "mi
Top 10 Healthcare Technology Stocks To Watch For 2014: General Communication Inc.(GNCMA)
General Communication, Inc. provides communication services to residential and business customers under the GCI and Alaska Wireless brand names in Alaska. The company?s Consumer segment provides local and long distance voice services; video services and products, including cable, high-definition television, digital video recorder, premium channel programming, video on demand, and pay-per-view programming services; Internet access; and fixed and mobile wireless voice and data services. This segment also sells handsets, personal computer wireless data cards, and accessories to residential customers; and offers bundled services and products, which comprise long-distance, cable television, cable modem Internet access, local access, and wireless services. Its Network Access segment provides interstate and intrastate-switched message telephone, multi-protocol label switching, frame relay, private line and dedicated Internet, and wireless services to GSM and CDMA wireless carrie rs. The company?s Commercial segment offers local and long distance communication, video, Internet, data network, managed, wireless, and bundled products and services. Its Managed Broadband segment offers Internet access, data network, and managed services to rural school districts, hospitals, and health clinics. The company?s Regulated Operations segment provides wireline communications services, including local access and long-distance, and Internet services and products, to residential, business, and governmental customers in areas of rural Alaska. General Communication, Inc. sells its services primarily through direct contact marketing, as well as through local media advertising, and its retail stores and Website. As of December 31, 2011, it had approximately 87,900 long-distance customers, 138,100 local access lines in service, 142,600 basic cable subscribers, 139,900 wireless subscribers, and 119,400 cable modem subscribers. The company was founded in 1979 and is bas ed in Anchorage, Alaska.
Advisors' Opinion:- [By Dan Radovsky]
Alaska Communications and General Communication (NASDAQ: GNCMA ) -- also known as GCI -- have finalized the transaction they proposed last summer to form The Alaska Wireless Network, or AWN, both companies announced today.
- [By Dan Radovsky]
Alaska Communications and General Communications, (NASDAQ: GNCMA ) , or GCI, today signed the network sharing agreement they proposed last summer.
- [By Lisa Levin]
Long Distance Carriers: This industry fell 1.97% by 10:50 am ET. General Communication (NASDAQ: GNCMA) shares dropped 2.2% in today's trading. General Communication's trailing-twelve-month profit margin is 0.98%.
Top 10 Healthcare Technology Stocks To Watch For 2014: Pluristem Therapeutics Inc.(PSTI)
Pluristem Therapeutics Inc., a bio-therapeutic company, engages in the research, development, and commercialization of standardized cell therapy products for the treatment of life threatening diseases. The company?s products are derived from human placenta, a non-controversial, non-embryonic, adult cell source. Its Placental adherent stromal cells are grown in the company's proprietary PluriX three-dimensional process that allows cells to grow in a natural environment. The company provides PLX-PAD that has completed Phase I clinical trials for people suffering from peripheral artery disease. It also offers various product candidates for diabetic foot ulcers, adjuvant hip replacement surgery, athletic injuries, inflammatory bowel disease, multiple sclerosis, neuropathic pain, ischemic stroke, adjuvant for UCB transplantation, and radiation exposure. The company was formerly known as Pluristem Life Systems Inc. and changed its name to Pluristem Therapeutics Inc. in November 2007. Pluristem Therapeutics Inc. was founded in 2001 and is headquartered in Haifa, Israel.
Advisors' Opinion:- [By John Udovich]
Stem cell stocks have not exactly been the best performers lately in part because the controversy over their use has died down over the years while major breakthroughs have been few or far between, but the industry along with small cap stem cell stocks Pluristem Therapeutics Inc (NASDAQ: PSTI), BioTime, Inc (NYSEMKT: BTX) and BioRestorative Therapies (OTCBB: BRTX) are still quietly producing their share of news or minor breakthroughs worth taking note of. Just consider the following stem cell news or news from small cap players in the sector:
- [By James E. Brumley]
Traders may not want to get married for the long haul to any of them, but for speculators looking for a quick, profitable hit, Arca Biopharma Inc. (NASDAQ:ABIO), Pluristem Therapeutics Inc. (NASDAQ:PSTI), and Bacterin International Holdings Inc. (NYSEMKT:BONE) may be better-than-average bets. Here's why.
No comments:
Post a Comment